« Return to News | R&D Trends

HR+Survey Solutions CRO study finds high employee turnover rate

Friday, August 16, 2013 01:38 PM

According to the 14th annual CRO Industry Global Compensation and Turnover Survey, conducted by HR+Survey Solutions, a compensation and research firm, CRO employees are leaving for new jobs at higher rates than their counterparts in other industries.

The CRO industry experienced 12.5% voluntary separation (left for new position with higher compensation and/or greater opportunity) as compared to a 1.5% national voluntary turnover rate in 2012. Findings shows 65% of CROs use sign-on bonuses to lure new talent, yet less than one third (29%) utilize retention bonuses to retain employees.

“The survey indicates that there is tremendous movement within the CRO industry. The reasons remain multi-faceted, but these numbers continue to be a concern in an industry that has seen double digit growth and where companies’ greatest assets are their talent,” said Judy Canavan, partner, HR+Survey Solutions. “CROs should consider solutions that foster retention of talent and institutional knowledge, including the use of stay bonuses, which are earned over time.”

According to HR+Survey Solutions, high employee turnover rates can be particularly damaging to CROs as pharmaceutical companies assess their turnover rates when making decisions about outsourcing clinical trials.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.